Bioventus Inc. SEC filings BVS
Bioventus Inc. has 463 filings in SEC EDGAR's recent list, going back to Apr 19, 2016. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 26, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2025 | — |
| EFFECT | Filing | Nov 4, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2024 | — |
| CORRESP | Letter to the SEC | Nov 1, 2024 | — |
| NT 10-Q | Filing | May 11, 2023 | Apr 1, 2023 |
| NT 10-K | Filing | Mar 16, 2023 | Dec 31, 2022 |
| NT 10-Q | Filing | Nov 16, 2022 | Oct 1, 2022 |
| 425 | Filing | Oct 18, 2021 | — |
| EFFECT | Filing | Sep 24, 2021 | — |
| CORRESP | Letter to the SEC | Sep 22, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2021 | — |
| 425 | Filing | Jul 30, 2021 | — |
| 425 | Filing | Jul 29, 2021 | — |
| 425 | Filing | Jul 29, 2021 | — |
| 425 | Filing | Jul 29, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 12, 2021 | — |
| CERT | Filing | Feb 11, 2021 | — |
| 8-A12B | Filing | Feb 11, 2021 | — |
| EFFECT | Filing | Feb 10, 2021 | — |
| CORRESP | Letter to the SEC | Feb 10, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2021 | — |
| CORRESP | Letter to the SEC | Feb 8, 2021 | — |
| CORRESP | Letter to the SEC | Feb 8, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| SEC STAFF LETTER | Filing | Jan 27, 2021 | — |
| DRSLTR | Filing | Dec 30, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 19, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2020 | — |
| DRS/A | Filing | Nov 10, 2020 | — |
| DRSLTR | Filing | Nov 9, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2020 | — |
| DRS | Filing | Oct 6, 2020 | — |
| CERTNAS | Auto-generated paper document | Aug 8, 2016 | — |
| RW | Filing | Aug 2, 2016 | — |
| CERTNAS | Auto-generated paper document | Jul 27, 2016 | — |
| 8-A12B | Filing | Jul 26, 2016 | — |
| DRS/A | Filing | May 27, 2016 | — |
| DRS | Filing | Apr 19, 2016 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BVS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Accelerated filer, Emerging growth company
- SEC CIK
- 1665988
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.